The global telepathology market was valued at USD 22.58 billion in 2024 and is expected to reach USD 69.99 billion by 2032, growing at a compound annual growth rate (CAGR) of 16.5% during the forecast period. In 2025, the market is projected to reach USD 24.07 billion. North America led the telepathology market in 2024, accounting for a dominant share of 46.89%.

The telepathology market is witnessing substantial growth as healthcare systems increasingly adopt digital solutions for remote diagnostics and pathology services. Telepathology enables the transmission of high-resolution pathological images over telecommunication networks, allowing specialists to examine and diagnose tissue samples without being physically present. This technology is particularly valuable in addressing the global shortage of pathologists and improving access to quality diagnostic services in remote and underserved areas. Advancements in digital imaging, artificial intelligence, and cloud-based platforms are further driving the market forward. As the demand for faster, more accurate, and collaborative diagnostic workflows grows, the telepathology market is poised for significant expansion across hospitals, laboratories, academic institutions, and telehealth providers worldwide.

Continue reading for more details: https://www.fortunebusinessinsights.com/telepathology-market-112685

Market Segmentation

• By component, the telepathology market includes hardware (scanners, microscopes), software, and services.
• Based on modality, the telepathology market is segmented into static, real‑time (dynamic), and hybrid systems.
• For application, the telepathology market serves oncology diagnostics, histopathology, cytopathology, intraoperative consultations, and education.
• By end‑user, the telepathology market caters to hospitals, diagnostic labs, academic/research institutions, and telehealth providers.
• The telepathology market also segments based on deployment: on‑premises and cloud‑based solutions.

List Of Key Telepathology Companies Profiled:

• Krsnaa Diagnostics Ltd. (India)
• OptraScan (U.S.)
• CompuMed, Inc. (U.S.)
• Diagnostic Instruments, Inc. (U.S.)
• UCLA Health (U.S.)
• Grundium Ltd (Finland)